a strong trendp = 0.06
Intriguingly, MCD tumors within Cluster 2 showed significantly poorer OS and a strong trend toward worse PFS ( p = 0.06) compared to MCD tumors in Cluster 1, while EZB cases did not show such differences.
Intriguingly, MCD tumors within Cluster 2 showed significantly poorer OS and a strong trend toward worse PFS ( p = 0.06) compared to MCD tumors in Cluster 1, while EZB cases did not show such differences.
6 A), whereas PFS showed a clear trend toward worse outcomes in the unclassified group (Fig. 6 B).
In both analyses, the unclassified subtype did not reach statistical significance for either OS or PFS.
Although the unclassified subtype lacks a defined biological identity in current classification systems, our findings suggest that, within this single-center cohort, Unclassified subtype clustered exclusively within the high-risk group and showed a trend toward inferior PFS.
Importantly, patients in Cluster 2 also had more adverse clinical features, including higher Ann Arbor stage and IPI, with elevated LDH levels trending toward significance.